New technologies for organ replacement and augmentation

Mayo Clinic Proceedings

Volumn 80, Issue 3, 2005, Pages 370-378

  Cascalho, Marilia ^a,b   Platt, Jeffrey L ^a,b  

^a Mayo Clinic   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN;

ALLOGRAFT; ARTIFICIAL ORGAN; AUTOGRAFT; CAUSE OF DEATH; CELLULAR IMMUNITY; CLONING; DEFIBRILLATOR; DISABILITY; DRASH SYNDROME; GRAFT REJECTION; HEART DISEASE; HEART FAILURE; HUMAN; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; LIVER DISEASE; LUNG DISEASE; NEPHROBLASTOMA; NONHUMAN; ORGAN TRANSPLANTATION; ORGANOGENESIS; PANCREAS DISEASE; REVIEW; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; XENOGRAFT; XENOTRANSPLANTATION;

EID: 14644430334     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/80.3.370     Document Type: Review

References (74)

1. Carrel A. Transplantation in mass of the kidneys. J Exp Med. 1908;10: 98-140.
2. Ullman E. Tissue and organ transplantation. Ann Surg. 1914;60:195-219.
3. Guthrie CC. Blood-Vessel Surgery and Its Applications. New York, NY: Longmans, Green & Co; 1912.
4. Calne RY. The rejection of renal homografts: inhibition in dogs by 6-mercaptopurine. Lancet. 1960;1:417-418.
5. Merrill JP, Murray JE, Takacs FJ, Hager EB, Wilson RE, Dammin GJ. Successful transplantation of kidney from a human cadaver. JAMA. 1963;185:347-353.
6. 2001 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry for Transplant Recipients: Transplant Data 1991-2000. Department of Health and Human Services, Health Resources and Services Administration, Office of Special Programs, Division of Transplantation, Rockville, Md; United Network for Organ Sharing, Richmond, Va; University Renal Research and Education Association, Ann Arbor, Mich. Available at: www.optn.org/data/annualReport.asp. Accessed December 9, 2002.
7. Evans RW. Coming to terms with reality: why xenotransplantation is a necessity. In: Platt JL, ed. Xenotransplantation. Washington, DC: ASM Press; 2001:29-51.
8. Platt JL. Preface: future approaches to replacement of organs. Am J Transplant. 2004;4(suppl 6):5-6.
9. Cascalho M, Platt JL. The immunological barrier to xenotransplantation. Immunity. 2001;14:437-446.
10. Galili U. Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today. 1993;14:480-482.
11. Alter BJ, Bach FH. Cellular basis of the proliferative response of human T cells to mouse xenoantigens. J Exp Med. 1990;171:333-338.
12. Dorling A, Lombardi G, Binns R, Lechler RI. Detection of primary direct and indirect human anti-porcine T cell responses using a porcine dendritic cell population. Eur J Immunol. 1996;26:1378-1387.
13. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science. 1996;272:50-53.
14. Carroll MC. The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol. 1998;16:545-568.
15. Kaufman DB, Platt JL, Rabe FL, Dunn DL, Bach FH, Sutherland DE. Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts. J Exp Med. 1990;172:291-302.
16. Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol. 1999;10:167-181.
17. Waaga AM, Gasser M, Laskowski I, Tilney NL. Mechanisms of chronic rejection. Curr Opin Immunol. 2000;12:517-521.
18. Cozzi E, White DJ. The generation of transgenic pigs as potential organ donors for humans. Nat Med. 1995;1:964-966.
19. McCurry KR, Kooyman DL, Alvarado CG, et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med. 1995;1:423-427.
20. Lai L, Kolber-Simonds D, Park KW, et al. Production of α-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science. 2002;295:1089-1092.
21. Dai Y, Vaught TD, Boone J, et al. Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol. 2002;20:251-255.
22. Platt JL. Knocking out xenograft rejection. Nat Biotechnol. 2002;20:231-232.
23. Zheng XX, Sanchez-Fueyo A, Domenig C, Strom TB. The balance of deletion and regulation in allograft tolerance. Immunol Rev. 2003;196:75-84.
24. Walsh PT, Strom TB, Turka LA. Routes to transplant tolerance versus rejection: the role of cytokines. Immunity. 2004;20;121-131.
25. Wekerle T, Sykes M. Induction of tolerance. Surgery. 2004;135:359-364.
26. Di Michele DM. Immune tolerance: a synopsis of the international experience. Haemophilia. 1998;4:568-573.
27. Mackall CL, Fleisher TA, Brown MR, et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med. 1995;332:143-149.
28. Thomas JM, Hubbard WJ, Sooudi SK, Thomas FT. STEALTH matters: a novel paradigm of durable primate allograft tolerance. Immunol Rev. 2001;183:223-233.
29. Cosimi AB, Sachs DH. Mixed chimerism and transplantation tolerance. Transplantation. 2004;77:943-946.
30. Graca L, Thompson S, Lin CY, Adams E, Cobbold SP, Waldmann H. Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance. J Immunol. 2002;168:5558-5565.
31. Samstein B, Platt JL. Xenotransplantation and tolerance. Philos Trans R Soc Lond B Biol Sci. 2001;356:749-158.
32. Hoerbelt R, Madsen JC. Feasibility of xeno-transplantation. Surg Clin North Am. 2004;84:289-307.
33. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol. 2002;30:42-48.
34. Fandrich F, Lin X, Chai GX, et al. Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat Med. 2002;8:171-178.
35. Koch CA, Platt JL. Natural mechanisms for evading graft rejection: the fetus as an allograft. Springer Semin Immunopathol. 2003;25:95-117.
36. Schmoeckel M, Bhatti FN, Zaidi A, et al. Orthotopic heart transplantation in a transgenic pig-to-primate model [published correction appears in Transplantation. 1998;66:943]. Transplantation. 1998;65:1570-1577.
37. Daggett CW, Yeatman M, Lodge AJ, et al. Total respiratory support from swine lungs in primate recipients. J Thorac Cardiovasc Surg. 1998;115:19-27.
38. Sablinski T, Latinne D, Gianello P, et al. Xenotransplantation of pig kidneys to nonhuman primates, I: development of the model. Xenotransplantation. 1995;2:264-270.
39. Ramirez P, Chavez R, Majado M, et al. Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation. 2000;70:989-998.
40. Pipeleers D. The biosociology of pancreatic B cells. Diabetologia. 1987;30:277-291.
41. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets [published correction appears in Science. 2001;293:428]. Science. 2001;292:1389-1394.
42. Murry CE, Wiseman RW, Schwartz SM, Hauschka SD. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest. 1996;98:2512-2523.
43. Taylor DA, Atkins BZ, Hungspreugs P, et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation [published correction appears in Nat Med. 1998;4:1200]. Nat Med. 1998;4:929-933.
44. Fukuda K. Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering. Artif Organs. 2001;25:187-193.
45. Bianco P, Robey PG. Stem cells in tissue engineering. Nature. 2001;414:118-121.
46. Griffith LG, Naughton G. Tissue engineering - current challenges and expanding opportunities. Science. 2002;295:1009-1014.
47. Rose EA, Gelijns AC, Moskowitz AJ, et al, Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;345:1435-1443.
48. Copeland JG, Smith RG, Arabia FA, et al, CardioWest Total Artificial Heart Investigators. Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med. 2004;351:859-867.
49. Jaboulay M. De reins au pli du coude par soutures arterielles et veineuses. Lyon Med. 1906;107:575-577.
50. Starzl TE, Fung J, Tzakis A, et al. Baboon-to-human liver transplantation. Lancet. 1993;341:65-71.
51. Mueller YM, Davenport C, Ildstad ST. Xenotransplantation: application of disease resistance. Clin Exp Pharmacol Physiol. 1999;26:1009-1012.
52. Cascalho M, Platt JL. Xenotransplantation and other means of organ replacement. Nat Rev Immunol. 2001;1:154-160.
53. Boneva RS, Folks TM, Chapman LE. Infectious disease issues in xenotransplantation. Clin Microbiol Rev. 2001;14:1-14.
54. Ogle BM, Butters KA, Plummer TB, et al. Spontaneous fusion of cells between species yields transdifferentiation and retroviral transfer in vivo. FASEB J. 2004;18:548-550.
55. Fuchs E, Segre JA. Stem cells: a new lease on life. Cell. 2000;100:143-155.
56. Krause DS, Theise ND, Collector MI, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 2001;105:369-377.
57. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701-705.
58. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114:763-776.
59. Lanza RP, Chung HY, Yoo JJ, et al. Generation of histocompatible tissues using nuclear transplantation. Nat Biotechnol. 2002;20:689-696.
60. Rideout WM III, Eggan K, Jaenisch R. Nuclear cloning and epigenetic reprogramming of the genome. Science. 2001;293:1093-1098.
61. Leobon B, Garcin I, Menasche P, Vilquin JT, Audinat E, Charpak S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A. 2003;100:7808-7811.
62. Vacanti CA, Langer R, Schloo B, Vacanti JP. Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation. Plast Reconstr Surg. 1991;88:753-759.
63. Nerem RM, Ensley AE. The tissue engineering of blood vessels and the heart. Am J Transplant. 2004;4(suppl 6):36-42.
64. Steer DL, Nigam SK. Developmental approaches to kidney tissue engineering. Am J Physiol Renal Physiol. 2004;286:F1-F7.
65. Grobstein C. Inductive epitheliomesenchymal interaction in cultured organ rudiments of the mouse. Science. 1953;118:52-55.
66. Dekel B, Burakova T, Ben-Hur H, et al. Engraftment of human kidney tissue in rat radiation chimera, II: human fetal kidneys display reduced immunogenicity to adoptively transferred human peripheral blood mononuclear cells and exhibit rapid growth and development. Transplantation. 1997;64:1550-1558.
67. Hammerman MR. Xenotransplantation of renal primordial [editorial]. Curr Opin Nephrol Hypertens. 2002;11:11-16.
68. Rogers SA, Lowell JA, Hammerman NA, Hammerman MR. Transplantation of developing metanephroi into adult rats. Kidney Int. 1998;54:27-37.
69. Rogers SA, Hammerman MR. Transplantation of rat metanephroi into mice. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1865-R1869.
70. Ogle B, Cascalho M, Platt JL. Fusion of approaches to the treatment of organ failure. Am J Transplant. 2004;4(suppl 6):74-77.
71. Sariola H. Interspecies chimeras: an experimental approach for studies on embryonic angiogenesis. Med Biol. 1985;63:43-65.
72. Bach FH, Winkler H, Ferran C, Hancock WW, Robson SC. Delayed xenograft rejection. Immunol Today. 1996;17:379-384.
73. Ogle BM, Platt JL. Genetic therapies and xenotransplantation. Expert Opin Biol Ther. 2002;2:299-310.
74. Sayegh MH, Platt JL. Overview: future approaches to renal replacement and regeneration. J Am Soc Nephrol. 2004;15:1105.